The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-(4-(methylthio)phenethyl)-2-(4-oxo-4,5-dihydro-3H-pyridazino[4,5-b]indol-3-yl)acetamide ID: ALA1478102
PubChem CID: 135410390
Max Phase: Preclinical
Molecular Formula: C21H20N4O2S
Molecular Weight: 392.48
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CSc1ccc(CCNC(=O)Cn2ncc3c([nH]c4ccccc43)c2=O)cc1
Standard InChI: InChI=1S/C21H20N4O2S/c1-28-15-8-6-14(7-9-15)10-11-22-19(26)13-25-21(27)20-17(12-23-25)16-4-2-3-5-18(16)24-20/h2-9,12,24H,10-11,13H2,1H3,(H,22,26)
Standard InChI Key: ZCTAMHGECGPHLM-UHFFFAOYSA-N
Molfile:
RDKit 2D
28 31 0 0 0 0 0 0 0 0999 V2000
5.6635 2.0565 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
-0.0523 2.0565 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.6622 2.4690 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.6527 1.2496 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.7667 3.2940 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.4812 3.7065 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.3767 3.7065 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.1957 2.4690 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.4812 2.0565 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.8088 1.9170 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.4732 1.1633 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.7667 2.4690 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.1957 3.2940 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.6293 2.0032 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.9581 0.4959 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.0523 3.7065 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.1142 1.3358 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.7786 0.5821 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.6622 3.2940 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5201 3.2940 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.0911 3.2940 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8056 3.7065 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9490 2.4690 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2346 3.7065 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5201 2.4690 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9490 3.2940 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2346 2.0565 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.3780 2.4690 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 23 1 0
1 28 1 0
2 12 2 0
3 19 2 0
4 9 1 0
4 11 1 0
5 6 1 0
5 12 1 0
5 16 1 0
6 13 2 0
7 19 1 0
7 21 1 0
8 9 2 0
8 10 1 0
8 13 1 0
9 12 1 0
10 11 2 0
10 14 1 0
11 15 1 0
14 17 2 0
15 18 2 0
16 19 1 0
17 18 1 0
20 22 1 0
20 24 2 0
20 25 1 0
21 22 1 0
23 26 2 0
23 27 1 0
24 26 1 0
25 27 2 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 392.48Molecular Weight (Monoisotopic): 392.1307AlogP: 2.96#Rotatable Bonds: 6Polar Surface Area: 79.78Molecular Species: NEUTRALHBA: 5HBD: 2#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 10.39CX Basic pKa: ┄CX LogP: 2.77CX LogD: 2.77Aromatic Rings: 4Heavy Atoms: 28QED Weighted: 0.49Np Likeness Score: -1.49
References 1. Lidumniece E, Withers-Martinez C, Hackett F, Blackman MJ, Jirgensons A.. (2022) Subtilisin-like Serine Protease 1 (SUB1) as an Emerging Antimalarial Drug Target: Current Achievements in Inhibitor Discovery., 65 (19.0): [PMID:36137276 ] [10.1021/acs.jmedchem.2c01093 ]